Skip to main content
  •   

    New Concepts in Atrophy and Fibrosis in Neovascular AMD

    Retina Subspecialty Day 2023
    Retina/Vitreous

    In this presentation from Retina Subspecialty Day 2023, Dr. Sadda discusses some suboptimal outcomes after anti-VEGF therapies for neovascular AMD, notably loss of vision from atrophy and fibrosis, and reviews new and upcoming treatments.